InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Sunday, 08/19/2018 8:33:51 PM

Sunday, August 19, 2018 8:33:51 PM

Post# of 5638
from Q2 transcript

The exercise of the warrants for example, but in the near term, we will probably look at some form of equity, we are also evaluating debt as well and so all of that would come likely after the Phase 3 data, but our objective is to sort of manage solution for the existing shareholders so that we can sort of preserve value and get people the upside that we think exists in the stock today.

https://seekingalpha.com/article/4198356-histogenics-corporation-hsgx-ceo-adam-gridley-q2-2018-results-earnings-call-transcript?page=7

technically he didn't lie. But if they announced the data Monday morning it would be in line. The positive spin, would be that bad news is out of the way, which includes Monday if no Data press release.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News